DaVita
DVA
#1511
Rank
A$21.21 B
Marketcap
A$330.51
Share price
2.49%
Change (1 day)
48.30%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$16.39

According to DaVita's latest financial reports the company's current EPS (TTM) is A$15.94. In 2025 the company made an earnings per share (EPS) of A$14.67 a decrease over its 2024 EPS that were of A$15.99.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$16.3911.77%
2025A$14.67-8.25%
2024A$15.9944.94%
2023A$11.0327.26%
2022A$8.67-35.56%
2021A$13.4544.1%
2020A$9.3319.7%
2019A$7.80540.48%
2018A$1.22-76.07%
2017A$5.09-19.31%
2016A$6.30242.52%
2015A$1.84-62.87%
2014A$4.9613.43%
2013A$4.378.45%
2012A$4.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$35.23 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$16.47 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$28.19 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.80-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA